SQSTM1 and breast carcinoma: Feng et al (Feng et al., 2017) revealed that tamoxifen, a drug commonly used in breast cancer, stimulated nuclear factor E2-related factor 2-dependent SQSTM1 transcription and promoted endometrial hyperplasia via activation of protein kinase Cδ.